These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 10925094

  • 1. Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer.
    Ito K, Yamamoto T, Kubota Y, Suzuki K, Fukabori Y, Kurokawa K, Yamanaka H.
    Urology; 2000 Aug 01; 56(2):278-82. PubMed ID: 10925094
    [Abstract] [Full Text] [Related]

  • 2. Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma.
    el-Galley RE, Petros JA, Sanders WH, Keane TE, Galloway NT, Cooner WH, Graham SD.
    Urology; 1995 Aug 01; 46(2):200-4. PubMed ID: 7542822
    [Abstract] [Full Text] [Related]

  • 3. Clinical usefulness of free PSA in early detection of prostate cancer.
    Luboldt HJ, Swoboda A, Börgermann C, Fornara P, Rübben H, Early Detection Project Group of the German Society of Urology.
    Onkologie; 2001 Feb 01; 24(1):33-7. PubMed ID: 11441278
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
    Gohji K, Nomi M, Egawa S, Morisue K, Takenaka A, Okamoto M, Ohori M, Fujii A.
    Cancer; 1997 May 15; 79(10):1969-76. PubMed ID: 9149025
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL.
    Törnblom M, Norming U, Adolfsson J, Becker C, Abrahamsson PA, Lilja H, Gustafsson O.
    Urology; 1999 May 15; 53(5):945-50. PubMed ID: 10223488
    [Abstract] [Full Text] [Related]

  • 7. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.
    Bangma CH, Kranse R, Blijenberg BG, Schröder FH.
    Urology; 1995 Dec 15; 46(6):779-84. PubMed ID: 7502415
    [Abstract] [Full Text] [Related]

  • 8. Efficiency of prostate-specific antigen and digital rectal examination in screening, using 4.0 ng/ml and age-specific reference range as a cutoff for abnormal values.
    Crawford ED, Leewansangtong S, Goktas S, Holthaus K, Baier M.
    Prostate; 1999 Mar 01; 38(4):296-302. PubMed ID: 10075009
    [Abstract] [Full Text] [Related]

  • 9. Determination of the percentage of free prostate-specific antigen helps to avoid unnecessary biopsies in men with normal rectal examinations and total prostate-specific antigen of 4-10 ng/ml.
    Martínez-Piñeiro L, Tabernero A, Contreras T, Madero R, Lozano D, López-Tello J, Alonso-Dorrego JM, Picazo ML, González Gancedo P, Martínez-Piñeiro JA, de La Peña JJ.
    Eur Urol; 2000 Mar 01; 37(3):289-96. PubMed ID: 10720854
    [Abstract] [Full Text] [Related]

  • 10. Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves.
    Catalona WJ, Hudson MA, Scardino PT, Richie JP, Ahmann FR, Flanigan RC, DeKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, Waters WB, MacFarlane MT, Southwick PC.
    J Urol; 1994 Dec 01; 152(6 Pt 1):2037-42. PubMed ID: 7525995
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of different prostate-specific antigen cutpoints for early detection of prostate cancer: results of a large screening study.
    Reissigl A, Pointner J, Horninger W, Ennemoser O, Strasser H, Klocker H, Bartsch G.
    Urology; 1995 Nov 01; 46(5):662-5. PubMed ID: 7495117
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The cutoff level of free/total prostate specific antigen (f/t PSA) ratios in the diagnosis of prostate cancer: a validation study on a Turkish patient population in different age categories.
    Erol B, Gulpinar MT, Bozdogan G, Ozkanli S, Onem K, Mungan G, Bektas S, Tokgoz H, Akduman B, Mungan A.
    Kaohsiung J Med Sci; 2014 Nov 01; 30(11):545-50. PubMed ID: 25458043
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 NG/ML or less.
    Yamamoto T, Ito K, Ohi M, Kubota Y, Suzuki K, Fukabori Y, Kurokawa K, Yamanaka H.
    Urology; 2001 Dec 01; 58(6):994-8. PubMed ID: 11744475
    [Abstract] [Full Text] [Related]

  • 16. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves.
    Catalona WJ, Richie JP, deKernion JB, Ahmann FR, Ratliff TL, Dalkin BL, Kavoussi LR, MacFarlane MT, Southwick PC.
    J Urol; 1994 Dec 01; 152(6 Pt 1):2031-6. PubMed ID: 7525994
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. Prostate specific antigen.
    Lodding P, Aus G, Bergdahl S, Frösing R, Lilja H, Pihl CG, Hugosson J.
    J Urol; 1998 Mar 01; 159(3):899-903. PubMed ID: 9474178
    [Abstract] [Full Text] [Related]

  • 19. Prostate carcinoma screening in the county of Tyrol, Austria: experience and results.
    Reissigl A, Horninger W, Fink K, Klocker H, Bartsch G.
    Cancer; 1997 Nov 01; 80(9):1818-29. PubMed ID: 9351555
    [Abstract] [Full Text] [Related]

  • 20. Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter.
    Horninger W, Cheli CD, Babaian RJ, Fritsche HA, Lepor H, Taneja SS, Childs S, Stamey TA, Sokoll LJ, Chan DW, Brawer MK, Partin AW, Bartsch G.
    Urology; 2002 Oct 01; 60(4 Suppl 1):31-5. PubMed ID: 12384160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.